Presentation TCT 2025 TCT 755: Impact of SGLT2 Inhibitors on Outcomes After TAVR: A Real-World Propensity-Matched Analysis Presenter: Salman Zahid October 27, 2025 REGISTER for free or LOG IN to view this content TCT 2025 Up Next Presentation TCT 2025 TCT 757: Hypo-attenuated Leaflet Thickening and Response to Antithrombotic Strategy in TAVR Patients with Elevated Gradients Presenter: Noah Tregobov October 27, 2025 More slides + Presentation TCT 2025 TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial Presenter: Gabriela Tirado-Conte October 27, 2025 Presentation TCT 2025 TCT 501: Physiologic–Angiographic Discordance After Balloon Angioplasty within 15 minutes Presenter: Sodam Jung October 27, 2025 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation TCT 2025 TCT 757: Hypo-attenuated Leaflet Thickening and Response to Antithrombotic Strategy in TAVR Patients with Elevated Gradients Presenter: Noah Tregobov October 27, 2025
Presentation TCT 2025 TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial Presenter: Gabriela Tirado-Conte October 27, 2025
Presentation TCT 2025 TCT 501: Physiologic–Angiographic Discordance After Balloon Angioplasty within 15 minutes Presenter: Sodam Jung October 27, 2025